Regional Citrate Anticoagulation in Predilution Continuous Venovenous Hemofiltration Using Prismocitrate 10/2 Solution

Therapeutic Apheresis and Dialysis

Volumn 16, Issue 1, 2012, Pages 81-86

  Shum, Hoi Ping ^a   Chan, King Chung ^a   Yan, Wing Wa ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Acute renal failure; Anticoagulation; Citrate; Continuous renal replacement therapy

Indexed keywords

BICARBONATE; CALCIUM ION; CITRIC ACID; GLUCONATE CALCIUM; PRISMOCITRATE 10 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BODY WEIGHT; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; HUMAN; HYPERNATREMIA; MALE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; PATIENT SAFETY; PRIORITY JOURNAL; REGIONAL CITRATE ANTICOAGULATION; TREATMENT DURATION; TREATMENT OUTCOME; ULTRAFILTRATION;

ACUTE KIDNEY INJURY; AGED; ANTICOAGULANTS; CALCIUM GLUCONATE; CITRIC ACID; FEMALE; HEMODIALYSIS SOLUTIONS; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; SODIUM BICARBONATE;

EID: 84855916678     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.01001.x     Document Type: Article

References (19)

1. Uchino S, Bellomo R, Morimatsu H etal. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563-70.
2. Monti G, Herrera M, Kindgen-Milles D etal. The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI). Contrib Nephrol 2007;156:434-43.
3. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994;66:431-7.
4. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 1994;24:806-12.
5. Tillman J. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy. Nurs Crit Care 2009;14:191-9.
6. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 2002;28:1419-25.
7. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006;32:188-202.
8. Schmitz M, Taskaya G, Plum J etal. Continuous venovenous haemofiltration using a citrate buffered substitution fluid. Anaesth Intensive Care 2007;35:529-35.
9. Ooi E, Lim T, Lim N. Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration. Crit Care 2010;14(Suppl 11):S515.
10. Gibney N. Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration. 2007 [Accessed 18 Apr 2011.] Available from URL:
11. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-52.
12. Leung AK, Yan WW. Renal replacement therapy in critically ill patients. Hong Kong Med J 2009;15:122-9.
13. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-81.
14. Barletta JF, Barletta GM, Brophy PD, Maxvold NJ, Hackbarth RM, Bunchman TE. Medication errors and patient complications with continuous renal replacement therapy. Pediatr Nephrol 2006;21:842-5.
15. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001;89:233-6.
16. Ronco C, Bellomo R, Homel P etal. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
17. Palevsky PM, Zhang JH, O'Connor TZ etal. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
18. Bellomo R, Cass A, Cole L etal. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-38.
19. Jun M, Heerspink HJ, Ninomiya T etal. Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2010;5:956-63.